FFO
HURA icon

Fortitude Family Office’s TuHURA Biosciences HURA Stock Holding History

Fortitude Family Office’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Buy
+2
New +$5 ﹤0.01% 2263
2025
Q4 		– Sell
-208
Closed -$516 – 2165
2025
Q3 		$516 Buy
+208
New +$547 ﹤0.01% 1800

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fortitude Family Office's HURA Position: Q2 2026 in Review

Fortitude Family Office opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 2 shares worth $5. The stake represents ﹤0.01% of the portfolio and ranks #2263 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in HURA as recently as Q3 2025.

Fortitude Family Office first reported a position in HURA in Q3 2025 and has held it in 2 quarters since. The position peaked at $516 in Q3 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Fortitude Family Office held 2 shares of TuHURA Biosciences worth $5 as of Q2 2026.
  • TuHURA Biosciences was a new Fortitude Family Office position in Q2 2026.
  • TuHURA Biosciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2263 holding.
  • Fortitude Family Office first reported a position in TuHURA Biosciences in Q3 2025 and has held it in 2 quarters since.
  • Fortitude Family Office's TuHURA Biosciences position peaked at $516 in Q3 2025.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.